Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Insiders, hedge funds, and politicians trading Abbott Laboratories stock (NYSE:ABT) in Q1 2024

Published 2024-04-16, 10:55 a/m
© Reuters.  Insiders, hedge funds, and politicians trading Abbott Laboratories stock (NYSE:ABT) in Q1 2024
ABT
-

Quiver Quantitative - $ABT earnings are coming up. Here is a look at recent trades of $ABT by people who might have an edge.

Congress Members of Congress have disclosed trades of $ABT stock 3 times in the last quarter. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $ABT stock by members of Congress: - Representative Kathy E. Manning has traded $ABT 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 01/23. - Senator Carper, Thomas R. sold up to $15,000 on 01/17.

Company Insiders No recent insider trades of $ABT on record.

Institutions Here’s a breakdown of some of the largest recent moves of $ABT stock: - CAPITAL RESEARCH GLOBAL INVESTORS bought an estimated $819,699,746 of $ABT stock - JANUS HENDERSON GROUP PLC bought an estimated $415,051,766 of $ABT stock - BOSTON PARTNERS bought an estimated $407,565,687 of $ABT stock - PUTNAM INVESTMENTS LLC sold an estimated $404,301,383 of $ABT stock - JPMORGAN CHASE & CO sold an estimated $376,479,117 of $ABT stock

This article was originally published on Quiver Quantitative

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.